SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-009447
Filing Date
2018-05-10
Accepted
2018-05-10 16:33:17
Documents
17
Period of Report
2018-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K kmph20180503_8k.htm 8-K 25231
2 EXHIBIT 99.1 ex_112582.htm EX-99.1 146079
3 EXHIBIT 99.2 ex_112583.htm EX-99.2 7322
4 a12.jpg GRAPHIC 41124
5 a11.jpg GRAPHIC 93690
6 a10.jpg GRAPHIC 180568
7 a09.jpg GRAPHIC 131779
8 a08.jpg GRAPHIC 156026
9 a07.jpg GRAPHIC 72820
10 a06.jpg GRAPHIC 83538
11 a05.jpg GRAPHIC 80408
12 a04.jpg GRAPHIC 90472
13 a03.jpg GRAPHIC 56104
14 a02.jpg GRAPHIC 277380
15 a01.jpg GRAPHIC 41124
16 chart.jpg GRAPHIC 36357
17 kempharm.jpg GRAPHIC 10970
  Complete submission text file 0001437749-18-009447.txt   2043543
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 18823075
SIC: 2834 Pharmaceutical Preparations